Winthrop Capital Management’s Merck MRK Stock Holding History

Winthrop Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.47M	Buy	12,209 +220	+2%	+$25.4K	0.38%	54
2025 Q4	$1.26M	Sell	11,989 -1,720	-13%	-$161K	0.29%	62
2025 Q3	$1.15M	Buy	13,709 +458	+3%	+$37.7K	0.28%	66
2025 Q2	$1.05M	Sell	13,251 -1,013	-7%	-$80.5K	0.27%	68
2025 Q1	$1.28M	Buy	14,264 +279	+2%	+$26K	0.35%	59
2024 Q4	$1.38M	Buy	13,985 +792	+6%	+$81.7K	0.37%	61
2024 Q3	$1.5M	Sell	13,193 -50	-0.4%	-$5.94K	0.71%	26
2024 Q2	$1.64M	Buy	13,243 +218	+2%	+$28.1K	0.82%	24
2024 Q1	$1.72M	Buy	13,025 +156	+1%	+$19.2K	0.79%	27
2023 Q4	$1.4M	Buy	+12,869	New	+$1.34M	0.46%	46

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Winthrop Capital Management's MRK Position: Q1 2026 in Review

Winthrop Capital Management increased its Merck (MRK) stake by 1.8% in Q1 2026, buying an estimated $25.4K and bringing the position to 12,209 shares worth $1.47M. The position accounts for 0.38% of the portfolio, ranked #54.

Winthrop Capital Management first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.72M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Winthrop Capital Management held 12,209 shares of Merck worth $1.47M as of Q1 2026.
Winthrop Capital Management bought 220 Merck shares in Q1 2026, an estimated $25.4K.
Merck made up 0.38% of Winthrop Capital Management's portfolio in Q1 2026, its #54 holding.
Winthrop Capital Management first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
Winthrop Capital Management's Merck position peaked at $1.72M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Winthrop Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.